The FDA Order Against 23andMe Shows That in the Balance Between Regulation and Innovation...
By EsqSocial Corporation 26/11/13
The FDA order against 23andMe to stop genetic testing shows that in the balance between regulation and innovation the FDA occasionally must address an age old debate......
By: JD Supra Perspectives